DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Celgene (NASDAQ: CELG)

116.09 -0.11 (-0.09%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $116.09 -0.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $115.50
Previous Close $116.20
Daily Range $114.92 - $116.54
52-Week Range $74.00 - $129.06
Market Cap $92.1B
P/E Ratio 39.79
Dividend (Yield) $0.00 (0.0%)
Volume 2,651,131
Average Daily Volume 5,089,083
Current FY EPS $4.11

Sector

Healthcare

Industry

Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary

How Celgene Stock Is Breaking All the Rules

Celgene Corp. might look grossly overvalued based on its fundamentals. But a deeper look inside the company shows why the stock remains a compelling buy, despite its monstrous five-year run.

Jim Cramer Answers Your Twitter Questions on Tesla, Jarden, Williams-Sonoma, Wayfair

Biotech Stock Roundup: Eleven Bio Slumps on Eye Drug Data, Achillion Signs Deal with J&J - Analyst B

Biotech Stock Roundup: Eleven Bio Slumps on Eye Drug Data, Achillion Signs Deal with J&J - Analyst Blog

10 S&P 500 Companies to Have the Most Revenue Growth in 2015

Agios Gains on Fast Track Status for Leukemia Drug AG-120 - Analyst Blog

Celgene/Accelreon's Luspatercept Granted Fast Track Status - Analyst Blog

Biosimilars Vs Generics: History Does Not Repeat, It Rhymes

Trillium Therapeutics - A Compelling Investment At Current Levels

Celgene's Crohn's Disease Drug Prompts Lingering Questions

Health Care Sector Update for 05/18/2015: CELG, SGYP, EBIO

See More CELG News...

CELG's Top Competitors

CELG $116.09 (-0.09%)
Current stock: CELG
AMGN $163.59 (-0.15%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
$0.00 (0.00%)
Current stock: